These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4547673)

  • 1. Indoleamine antagonists: relative potencies as inhibitors of tryptamine- and 5-hydroxytryptophan-evoked responses.
    Clineschmidt BV; Lotti VJ
    Br J Pharmacol; 1974 Feb; 50(2):311-3. PubMed ID: 4547673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methergoline: a selective anti-tryptamine action in the rabbit hyperthermia model.
    Quock RM
    Proc West Pharmacol Soc; 1978; 21():447-9. PubMed ID: 308661
    [No Abstract]   [Full Text] [Related]  

  • 3. Tryptamine-induced myoclonus in guinea-pigs pretreated with a monoamine oxidase inhibitor indicates pre- and post-synaptic actions of tryptamine upon central indoleamine systems.
    Luscombe G; Jenner P; Marsden CD
    Neuropharmacology; 1982 Dec; 21(12):1257-65. PubMed ID: 6130489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of chlordiazepoxide, methysergide, and cinanserin as modifiers of punished behavior and as antagonists of N,N-dimethyltryptamine.
    Winter JC
    Arch Int Pharmacodyn Ther; 1972 May; 197(1):147-59. PubMed ID: 5064096
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of 5-hydroxytryptamine antagonists on spinal neuronal activity.
    Banna NR; Anderson EG
    J Pharmacol Exp Ther; 1968 Aug; 162(2):319-25. PubMed ID: 5302116
    [No Abstract]   [Full Text] [Related]  

  • 6. Peripheral serotonin antagonists: failure to antagonize serotonin in brain areas receiving a prominent serotonergic input.
    Haigler HJ; Aghajanian GK
    J Neural Transm; 1974; 35(4):157-273. PubMed ID: 4373531
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of tryptamine antagonists on self-stimulation. Interaction with amphetamine.
    Silveira Filho NG; Graeff FG
    Psychopharmacology (Berl); 1977 Mar; 52(1):87-92. PubMed ID: 403563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the mode of the prolactin release-inhibiting action of the serotonin receptor blockers metergoline, methysergide, and cyproheptadine.
    Krulich L; McCann SM; Mayfield MA
    Endocrinology; 1981 Apr; 108(4):1115-24. PubMed ID: 7472261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of 5-hydroxytryptaminergic antagonists upon apomorphine- and lergotrile-induced hypothermia and stereotyped behaviour in rats.
    Wade RL; Quock RM; Malone MH
    J Pharm Pharmacol; 1984 Oct; 36(10):673-6. PubMed ID: 6150084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral effects of N,N-diethyltryptamine: absence of antagonism by xylamidine tosylate.
    Winter JC
    J Pharmacol Exp Ther; 1969 Sep; 169(1):7-16. PubMed ID: 5306645
    [No Abstract]   [Full Text] [Related]  

  • 11. A role for an indoleamine other than 5-hydroxytryptamine in the hypothalamic thermoregulatory pathways of the rat.
    Cox B; Davis A; Juxon V; Lee TF; Martin D
    J Physiol; 1983 Apr; 337():441-50. PubMed ID: 6875941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of conflict behavior with cinanserin, a serotonin antagonist: reversal of the effect with 5-hydroxytryptophan and alpha-methyltryptamine.
    Geller I; Hartmann RJ; Croy DJ; Haber B
    Res Commun Chem Pathol Pharmacol; 1974 Jan; 7(1):165-74. PubMed ID: 4544101
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of the contractile response to serotonin and tryptamine of isolated dog cerebral, femoral and mesenteric arteries.
    Fu LH; Toda N
    Jpn J Pharmacol; 1983 Apr; 33(2):473-80. PubMed ID: 6604186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of serotonin antagonists on bulbospinal systems.
    Proudfit HK; Anderson EG
    Brain Res; 1973 Oct; 61():331-41. PubMed ID: 4773165
    [No Abstract]   [Full Text] [Related]  

  • 15. Myoclonus after 5-hydroxytryptophan in rats with lesions of indoleamine neurons in the central nervous system.
    Stewart RM; Growdon JH; Cancian D; Baldessarini RJ
    Neurology; 1976 Jul; 26(7):690-2. PubMed ID: 1084496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic interactions of methysergide and cinanserin on isolated human smooth muscle.
    Glegg AM; Turner P
    Arch Int Pharmacodyn Ther; 1971 Jun; 191(2):301-9. PubMed ID: 5089219
    [No Abstract]   [Full Text] [Related]  

  • 17. 5-HT-mediated myoclonus in the guinea pig as a model of brainstem 5-HT and tryptamine receptor action.
    Luscombe G; Jenner P; Marsden CD
    Adv Neurol; 1986; 43():529-43. PubMed ID: 2418649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responses of the flexor reflex to LSD, tryptamine, 5-hydroxytryptophan, methoxamine, and d-amphetamine in acute and chronic spinal rats.
    Nozaki M; Bell JA; Vaupel DB; Martin WR
    Psychopharmacology (Berl); 1977 Nov; 55(1):13-8. PubMed ID: 414256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of beta-phenylethylamine derivatives and serotonin blocking drugs upon serotonin, tryptamine and reserpine behavioral depression in mice.
    Saavedra JM; Fischer E
    Arzneimittelforschung; 1970 Jul; 20(7):952-7. PubMed ID: 5536068
    [No Abstract]   [Full Text] [Related]  

  • 20. Tryptamine-induced drug effects insensitive to serotoninergic antagonists: evidence of specific tryptaminergic receptor stimulation?
    Quock RM; Weick BG
    J Pharm Pharmacol; 1978 May; 30(5):280-3. PubMed ID: 26739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.